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httpcense.Abstract Objective: To assess the diagnostic value of high-frequency (MicroPure) ultrasound in
evaluating suspicious microcalciﬁcations and to determine its capability in biopsy guidance.
Subjects and methods: Sixty-two cases with suspicious microcalciﬁcations detected on mammo-
graphic examination had been re-evaluated by MicroPure US. The studied cases underwent true
cut tissue/surgical excision biopsy. Histopathology revealed 25 benign and 37 malignant lesions
and was considered the gold standard of reference.
Results: Malignant microcalciﬁcations were easier to be visible at MicroPure US, as they were
detected in 86.5% (n= 32/39) compared to only 68% (n= 17/25) of the benign lesions. US
depicted more breast masses associated with malignant microcalciﬁcations in 78% (n= 29/37) than
those associated with benign ones seen in 36% (n= 9/25).
Visibility of suspicious microcalciﬁcations at US was aided by preliminary mammogram. Given
known mammography location of these microcalciﬁcations had made their visualization accessible
by MicroPure US in 79% (n= 49) of the cases.
Conclusion: MicroPure ultrasound cannot discriminate benign from malignant breast microcalciﬁ-
cations. MicroPure can be useful in detecting clustered microcalciﬁcations that are not accessible by
B-mode ultrasound; provided knowledge of their mammographic location and thus can provide
better guidance for pre-surgical wire localization and ultrasound-guided biopsies.
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Detection of breast cancer is conducted by means of two most
widely used diagnostic methods, i.e., mammography and ultra-
sonography (US) imaging. These two methods are best suited
for unveiling different types of cancer (1).
Clustered microcalciﬁcations may be the only detectable
manifestation of early breast cancer (2,3).Production and hosting by Elsevier B.V.
.07.001
Table 1 Mammography detected microcalciﬁcations.
Mammography detected calciﬁcations No. (%)
Shape
Round 3 (4.8)
Punctate 5 (8)
Amorphous 13 (21)
Coarse heterogenous 33 (53.2)
Linear 8 (13)
Distribution
Clustered 53 (85.5)
Segmental 9 (14.5)
Note-Data are reported as number (percent).
500 S.M. Mansour, L. AdelMicrocalciﬁcations cannot be depicted with US when they
are located inside echogenic, ﬁbroglandular breast tissue be-
cause of the difﬁculty in differentiating them from the echo-
genic interfaces among tissues (4).
Mammography currently has a signiﬁcant advantage over
ultrasound in terms of its clinical usefulness for the diagnosis
of microcalciﬁcations in breast examinations. The main reason
is that in mammography, the probability of malignancy can be
assessed using established categories that are based on the
shape (small round, amorphous, pleomorphic, or ﬁne linear)
and distribution pattern (clustered, segmental, linear, regional,
or diffuse) of microcalciﬁcations (5).
After using a high-frequency transducer, some investigators
have reported that US depicted clustered microcalciﬁcations in
breast cancers. A hypoechoic background of tumor enhances
the ability of US to enable identiﬁcation of the hyperechoic
punctate calciﬁcations (6,7).Fig. 1 Invasive duct carcinoma (IDC) in 57-year-old patient. (a) D
upper central focal area of architectural distortion (arrow) with relat
thickening and parenchymal edematous changes. (b) Tomosynthesis
shapes. (c & d) MicroPure US, clearly visualizes the clustered calciﬁc
adherent (arrow) that was not identiﬁed in the mammogram.MicroPure is an image processing function that is designed
to improve the visualization of microcalciﬁcations that can be
detected but are difﬁcult to visually identify in B-mode images
due to the presence of speckle noise and surrounding tissues (8).
In this study we will focus on the capability of MicroPure
US to evaluate suspicious microcalciﬁcations and if it is possi-
ble to be used for differentiating between benign and malig-
nant clustered microcalciﬁcations using a mammography-
based approach and thus asses whether it is able to guide
biopsy for such lesions.2. Subjects and methods
2.1. Subjects
This study is a prospective analysis approved by the Ethics
committee in Wadi El-Neel Hospital, Cairo, Egypt, where
radiological examination of the study cases had been per-
formed in a well-equipped and organized breast imaging unit
incorporation with Institute Gustave-Roussy (IGR) – the lead-
ing European anticancer centre.
Sixty-two breast lesions that showed suspicious clusters of
microcalciﬁcations were evaluated by B-mode and MicroPure
US provided known location from preliminary performed dig-
ital mammography from May 2010 to September 2011.
Median age of the study cases was 38 years (range 31–72).
They presented either for assessment of sensible breast lumps
that needed diagnostic sonomammogram or were candidates of
screening mammogram with accidently discovered breast le-
sions. Such cases had a dominant suspicious microcalciﬁc clus-
ter on mammogram.igital mammography of the left breast MLO and CC views show
ed suspicious cluster of microcalciﬁcations. Note: associated skin
slices show more clariﬁed vision of the suspicious calciﬁcations
ations (arrow heads). A tiny hypoechoic mass could be detected
Fig. 2 Left breast conserving surgery in 46-year-old patient. One year post therapy follow up revealed contralateral Ductal carcinoma
in situ (DCIS) solid and cribriform patterns. (a) Right digital mammography MLO and CC view show a tiny cluster of microcalciﬁcations.
(b) Spot magniﬁcation view of the suspicious cluster (arrow). (c) US after processing with MicroPure, can visualize the calciﬁcations and
identify the suspicious cluster that only measures 4 mm. (d) Conventional US image of the right axillary nodes that show asymmetrical
cortical thickening and asymmetrical fatty hilum, features that enhance the suspicion of the detected cluster. (e) Post processing MRI
breast images show malignant kinetic criteria of the detected cluster region.
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Fig. 3 Forty-one-year-old patient with positive family history of breast cancer. Right breast lower inner quadrant lesion proved to be
sclerosing adenosis. (a) Right digital mammography MLO and CC views show dense breasts and powdery calciﬁcations carpeting the
glandular tissue. The lower inner quadrant displays suspicious segmental amorphous microcalciﬁcations associate with focal area of
connective tissue traction (arrow). (b) Tomosynthesis slices show more identiﬁcation of the suspicious calciﬁcations (circle). (c) MicroPure
ultrasound can easily identify the calciﬁcations than the B-mode version yet it could not discriminate the suspicious calciﬁcations that
warrant biopsy. Mammography-guided wire bracketing and surgical excision of the suspicious microcalciﬁcations was done.
502 S.M. Mansour, L. Adel2.2. Methods
Full ﬁeld digital mammography, high-resolution conventional
US and MicroPure US were performed for all cases evaluated
in the study.
2.2.1. Full ﬁeld digital mammography
Examination was performed using Hologic’s Selenia Dimen-
sions 3-D digital mammography tomosynthesis system. Stan-
dard craniocaudal and mediolateral oblique views were
obtained; with the axilla included in the latter.
2.2.2. Ultrasound examination
Conventional B-mode US and MicorPure images were ob-
tained using high-end ultrasound system (Aplio XG, Toshiba,
Japan) with a 12-MHz broadband linear transducer.
The scanning protocol included transverse and longitudinal
real-time imaging of lesions of question. A split-screen imaging
mode (twin images: B-mode andMicroPure); on theMicroPure
version; B-mode image is displayed in blue (Blue Layermethod).
2.3. Image analysis
Mammography reading, ultrasound performance (both gray
scale and MicroPure ultrasound) and imaging-guided interven-
tional procedures (tissue biopsy/wire localization) were per-
formed qualiﬁed consultants of radiology M.D. certiﬁed(lecturers – S.M. and A.L. – 10 and 15 years experience in
breast imaging and interventional procedures respectively).
The authors were blinded to the pathology results at the
time of initial evaluation. Also throughout the study, they were
blinded to each other’s ultrasound analysis. At the stage of ﬁ-
nal evaluation, there was a multidisciplinary discussion of
cases with the authors and the consultant breast surgeon about
the method of breast intervention to be used.
Based on mammography, the shape and distribution of the
detected calciﬁcations were assessed. In the current study the
shape of microcalciﬁcations included ﬁve patterns: (1) round,
(2) punctate, (3) amorphous, (4) coarse heterogeneous, and
(5) linear. The microcalciﬁcations were distributed in two man-
ners either (1) clustered or (2) segmental.
MicroPure US was done to check: (1) its capability in dis-
criminating benign from malignant microcalciﬁcations, (2)
the ability to replace surgical by real-time US guided tissue
biopsy and (3) the feasibility of performing US-guided wire
localization prior to surgery instead of mammography-guided
(an attempt to reduce radiation exposure).
MicroPure images were presented by the Blue Layer meth-
od and the extracted microcalciﬁcations displayed as ‘‘white
spots’’. Such condition identiﬁes the locations of the calciﬁca-
tions of question in the B-mode images.
Following Kurita, 2010 (8), MicroPure grads of analysis
are: grade 1 cannot be visually identiﬁed and grade 2 can be
clearly visually identiﬁed.
Table 2 Histologic diagnosis of detected microcalciﬁcations
and visibility on MicroPure.
Histologic diagnosis (n= 62) MicroPure US Total
Visible Not visible
Benign-25 (40.3)
Fibroadenosis 1 1 2 (3.2)
Sclerosing adenosis 3 1 4 (6.5)
Ductal hyperplasia without atypia 11 4 15 (24.2)
Atypical ductal hyperplasia 2 2 4 (6.5)
Malignant-37 (59.7)
DCIS 23 5 28 (45.1)
IDC 9 0 9 (14.5)
Total 49 (79) 13 (21) 62 (100)
Note-Data are reported as number (percent).
Fig. 4 Right breast conserving surgery in 36-year-old patient. On post therapy follow up suspicious cluster of microcalciﬁcations was
found at the presumed operative bed that was proved to be ductal hyperplasia with atypia. (a & b) Right digital mammography and
tomosynthesis slices in MLO and CC views show upper outer scar with related suspicious microcalciﬁc cluster. (c) US could not identify
the calciﬁcations of question at the given mammography location in spite of using the MicroPure capability.
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with invisible calciﬁcations on MicroPure US in 21% (n= 13)
prior to surgical excision of clustered microcalciﬁcations.
Mammography-guided wire bracketing was done in 14.5%
(n= 9) to suspicious segmental calciﬁcations.
In clustered calciﬁcations detected by mammography and
was visible by US, MicroPure US-guided core biopsies was
feasible in 21% (n= 13) cases.
MicroPure US-guided wire localization needed for surgical
biopsy (as requested by their referring physician) was done in
43.5% (n= 27).
In the latter two situations of MicroPure US-guidance of
breast interventional procedures; not only the calciﬁcations
visibility were feasible but also the needle tracking was much
easier.
3. Results
In the current work, MicroPure US was used to re-evaluate 62
lesions that represent suspicious microcalciﬁcations. Such cal-
ciﬁcations were ﬁrst detected and localized by mammography.
The histopathology revealed 25 benign and 37 malignant
microcalciﬁc arrangements.
The different shapes and distribution of the mammograph-
ically detected microcalciﬁcations in the study was listed in
Table 1.Malignant microcalciﬁcations were easier to be visible at
MicroPure US (Figs. 1 and 2) as they were detected in 86.5%
(n= 32/39) compared to only 68% (n= 17/25) of benign calci-
ﬁcations. Also benign calciﬁcations with precancerous element
(e.g. sclerosing adenosis and atypical ductal hyperplasia) were
denser and consequently clearer onMicroPure US examination
(Fig. 3), yet unfortunately few of them were invisible (Fig. 4).
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microcalciﬁcations (Figs. 1 and 2) in 78% (n= 29/37) than
those associated with benign ones seen in 36% (n= 9/25).
Malignant forms of microcalciﬁcations and related masses
were more frequently seen in invasive cancers (100%, 9/9) than
in DCIS (71%, 20/28).
The correlation of the histological diagnosis of these micro-
calciﬁcations and MicroPure grading was stated in Table 2.
Visibility of suspicious microcalciﬁcations at US was aided
by preliminary mammogram.
When the mammographic location of these calciﬁcations
were known, their visualization by MicroPure US was accessi-
ble in 79% (n= 49) of the cases.
Surgical/true cut biopsy outcomes for questionable lesions
were the standard reference.
4. Discussion
US is less sensitive for the demonstration of microcalciﬁcations
than is mammography. The smaller the calciﬁcation, the lower
the sensitivity of US in depicting them. However, the high-
frequency transducers currently being used can yield a higher
percentage of mammographically visible calciﬁcations than
could the lower-frequency transducers that were used previ-
ously (9–11).
According to Moon et al. (12), it is difﬁcult to visualize a
small cluster of calciﬁcations at US, particularly those less than
5 mm. In the current study the use of high frequency linear
transducer (12–13 MHz), was enhanced by MicroPure US
examination which had enabled the detection of tiny clusters
<5 mm in size (Fig. 2). The superimposition of a blue back-
ground in MicroPure had reduced or almost eliminated any
high-echoes expect calciﬁcations and so had enhanced the
identiﬁcation and localization of microcalciﬁcations. Also, ori-
ginal B-mode images using high frequency transducers had
better depiction of associated masses, if present (Fig. 1).
We had done experimental trials to assess the probability of
using MicroPure US in locating calciﬁcations without being
aware about their presence in previous mammogram fromFig. 5 Patient is 46-year-old with right breast IDC. (a) Digital mamm
malignant-looking dense mass and no glandular calciﬁcations. (b) F
conﬁrmed by the mammogram, M=Mass.the start. Such condition had wasted a very important advan-
tage of US being an easy and quick method of examination,
moreover it had failed to detect calciﬁcations in 96.7%
(n= 60) of the examined cases. Knowledge of calciﬁcations
presence in mammography without speciﬁcation of the in-
volved region helped a little in upgrading the examination
efﬁcacy. Visualization of calciﬁcations in the latter condition
was elicited in 11.3% (n= 7).
Provided known mammography location of suspicious mic-
rocalciﬁcations had made their visualization accessible by
MicroPure US in 79% (n= 49) of the cases.
We have to mention that focal clustered microcalciﬁcations
are those that beneﬁt from further examination by MicroPure
US following mammography-based localization (Figs. 1 and
2), while regional suspicious microcalciﬁcations especially if
they are apart from a diffuse mammary condition will not ben-
eﬁt from such examination; as in spite of being visualized, the
identiﬁcation of the suspicious microcalciﬁcations from the
non-suspicious ones is not accessible (Fig. 3). Moreover exact
extension of the process in most cases is not feasible, so at the
end either to do mammography-guided biopsy or wire bracket-
ing and surgical excision with no role for US in such case
regarding either imaging or management.
The assumption that US will more likely depict malignant
rather than benign calciﬁcation was proved in a prospective
study performed to determine the capability of US to visualize
masses associated with mammographically detected microcal-
ciﬁcations (4). They had stated that the visibility of calciﬁca-
tions within a mass by US cannot be used to distinguish
between benign and malignant disease as calciﬁcations may
be visible at US examination in some benign lesions and invis-
ible in some malignancies.
Calciﬁcations developing in the necrotic debris are typically
ﬁne, linear, branching, conforming to the linear shape and dis-
tribution of the ducts. They may also have segmental or regio-
nal distribution. These types of calciﬁcations are highly speciﬁc
for malignancy (13).
During our work we had found that US with the use of the
MicroPure capability were not able to distinguish the differentography CC view predominantly fatty parenchyma (ACR 1) shows
alse impression of glandular calciﬁcations by MicroPure US as
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masses and so was not able to distinguish benign from malig-
nant clusters.
Another major limitation is the false impression of micro-
calciﬁcations seen as high-echo spots on MicroPure US. Such
artifact is elicited by rapid movement of the used probe while
crossing the Cooper’s ligament at right angles (Fig. 5). It is a
very serious condition as it may lead to false-positive diagnos-
tic ﬁndings and consequent unnecessary biopsies, not to men-
tion the patient’s anxiety and future radiologists distrust.
However it may be suspected by its location being superﬁcial
(in the subcutaneous fat), and noted at the presumed location
of the Cooper’s ligament.
Sankaye et al. (14) had demonstrated MicroPure to be no
better at detecting benign or malignant mammographic calciﬁ-
cation than B-mode ultrasound. They declared that it would
only be useful if it detects calciﬁcations that are not visualized
with B-mode ultrasound, and therefore reduces X-ray-guided
biopsies.
US-guided procedures are less expensive and faster than
stereotactically guided procedures (15).
Stereotactic biopsy is a more invasive procedure that takes
up to 2 h, and it’s not very pleasant, on the other side with
MicroPure US, we can do an ultrasound-guided biopsy that
lasts for only 15–20 min. Also stereotactic devices are not
available in some institutions (being expensive and not fre-
quently a requested biopsy procedure) so an US machine with
MicroPure capability can extend the role of biopsy for ques-
tionable calciﬁcations.
Recommendation: In order to accurately diagnose microcal-
ciﬁcations using MicroPure, ﬁrst of all it is necessary to locate
them and asses their shapes and distribution on mammogra-
phy, then try to ﬁnd their expected site and re-asses them by
MicroPure ultrasound examination. If US-guided wire locali-
zation or wire bracketing is the requested procedure, a second
shot mammogram is needed after the procedure for conﬁrma-
tion that the targeted calciﬁcations are those required.
5. Conclusion
MicroPure US cannot discriminate benign from malignant
breast microcalciﬁcations.
MicroPure can be useful in detecting calciﬁcations that are
not accessible by B-mode ultrasound, and thus provide better
guidance for pre-surgical wire localization and ultrasound
guided biopsies; provided clustered (not segmental) microcalci-
ﬁcations and previous knowledge of their mammographic
location.
Ultrasound biopsy is quicker, cheaper and more comfort-
able for the patient than stereotactic biopsy. MicroPure US
by its capability in improving the visibility of clustered micro-
calciﬁcations is consequently desirable.Acknowledgment
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